NCT03246984View on ClinicalTrials.gov

VALUE- Vascular Access Laminate eUropean Experience. A Post Market Surveillance Study to Assess the Safety and Effectiveness of VasQ

NACompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

September 7, 2017

Primary Completion Date

January 11, 2021

Study Completion Date

January 11, 2021

Conditions
Arterio-Venous FistulaKidney Failure, ChronicKidney DiseasesRenal Failure ChronicESRDArteriovenous Fistula Thrombosis
Interventions
DEVICE

VasQ

VasQ device implantation in patients with a new brachiocephalic or radiocephalic fistula creation.

Trial Locations (11)

13353

Charité - Universitätsmedizin Berlin, Berlin

14467

Klinikum Ernst von Bergmann gemeinnützige GmbH, Potsdam

50937

University Hospital Cologne, Cologne

75014

Institut Mutualiste Montsouris, Paris

86156

Universitätsklinikum Augsburg, Augsburg

Unknown

Königin Elisabeth Krankenhaus Herzberge, Berlin

Universitaetsklinikum Jena, Jena

Harzklinikum Dorothea Christiane Erxleben, Wernigerode

09113

Klinikum Chemnitz gGmbH, Chemnitz

08036

Hospital Clinic of Barcelona, Barcelona

SE1 9RT

Guy's Hospital, London

Sponsors
All Listed Sponsors
lead

Laminate Medical Technologies

INDUSTRY

NCT03246984 - VALUE- Vascular Access Laminate eUropean Experience. A Post Market Surveillance Study to Assess the Safety and Effectiveness of VasQ | Biotech Hunter | Biotech Hunter